MIA2: A Protein Essential for ER-to-Cytoplasm Protein Export (G4253)

Target Name: MIA2

NCBI ID: G4253

MIA2

MIA2: A Protein Essential for ER-to-Cytoplasm Protein Export

MIA2, also known as MIA SH3 domain ER export factor 2, and transcript variant 9, is a protein that plays a crucial role in the export of proteins from the endoplasmic reticulum (ER) to the cytoplasm. The ER is a organelle responsible for the final processing and quality control of proteins before they are released into the cytoplasm for further degradation or degradation. The ER is the first destination for most proteins, and the efficient export of these proteins is critical for their proper functioning and for maintaining cellular homeostasis.

MIA2 is a member of the TIR (Toward an Understandable Image of the ER) superfamily, which includes proteins that play a key role in the ER-to-cytoplasm transport of various molecules, including cytoskeletal components, enzymes, and signaling proteins. The MIA2 The protein is characterized by a unique structure that consists of a nucleotide-binding oligomerization domain (NBD), a transmembrane region, and a cytoplasmic region.

The NBD is a nucleotide-binding domain that is known to play a critical role in the regulation of protein-protein interactions and in the recognition of various types of RNA molecules, including microRNAs. The NBD is also involved in the stability of the protein and in its interactions with other molecules, such as co-factors and other proteins.

The transmembrane region of MIA2 is characterized by a single-layer of lipid bilayer membrane structure and is responsible for the stability of the protein in the ER. This region is also involved in the regulation of protein-protein interactions and in the formation of protein-protein complexes.

The cytoplasmic region of MIA2 is a cytoplasmic tail that is responsible for the stability and localization of the protein in the cytoplasm. This region is also involved in the regulation of protein-protein interactions and in the formation of protein-protein complexes.

MIA2 is involved in the export of various proteins from the ER to the cytoplasm, including the export of enzymes, signaling proteins, and cytoskeletal components. It is also involved in the regulation of protein-protein interactions and in the formation of protein-protein complexes . These functions are critical for maintaining cellular homeostasis and for the proper functioning of various cellular processes.

MIA2 is also a potential drug target and biomarker. The NBD and cytoplasmic regions of MIA2 are thought to be involved in the regulation of protein-protein interactions and in the formation of protein-protein complexes, making them potential targets for small molecules or antibodies that can modulate these processes. Additionally, the transmembrane region of MIA2 is involved in the regulation of protein-protein interactions and in the formation of protein-protein complexes, making it a potential target for small molecules or antibodies that can modulate these processes.

In conclusion, MIA2 is a protein that plays a crucial role in the export of proteins from the ER to the cytoplasm. Its unique structure, including the NBD and cytoplasmic regions, makes it a potential drug target and biomarker. Further research is needed to fully understand the mechanisms of MIA2 and its role in cellular homeostasis.

Protein Name: MIA SH3 Domain ER Export Factor 2

Functions: Plays a role in the transport of cargos that are too large to fit into COPII-coated vesicles and require specific mechanisms to be incorporated into membrane-bound carriers and exported from the endoplasmic reticulum (PubMed:27138255, PubMed:21525241, PubMed:25202031, PubMed:27170179). Plays a role in the secretion of lipoproteins, pre-chylomicrons and pre-VLDLs, by participating in their export from the endoplasmic reticulum (PubMed:27138255). Thereby, may play a role in cholesterol and triglyceride homeostasis (By similarity). Required for collagen VII (COL7A1) secretion by loading COL7A1 into transport carriers and recruiting PREB/SEC12 at the endoplasmic reticulum exit sites (PubMed:21525241, PubMed:25202031, PubMed:27170179)

The "MIA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets